Table 7

 Sensitivity of the results to the discount rate for costs and effects, NCSP strategy (strategy 3, annual screening offer to men and women aged under 25 years compared with no screening).

PID rateDiscount rate effects (%)Discount rate costs (%)Net MOANet QALYNet costs (£)Cost (£)/MOACost (£)/QALY gained
NSCP, National Chlamydia Screening Programme; PID, pelvic inflammatory disease; MOA, major outcomes averted; QALY, quality adjusted life years.
1%00321111 644 8975118144 924
3.53.525571 386 4545432201 371
0.03.5321111 383 6444305121 907
6621951 236 6415641243 833
10%001187811 406 086118517 265
3.53.5924461 245 877134827 269
0.03.51187811 220 846102914 991
66786321 131 554143935 620
30%002996197959 6713204872
3.53.52334110973 2124178845
0.03.52996197911 0043044625
66198776922 86946412 081